Global Exosome Research Products Market

Exosome Research Products Market Size, Share, Growth Analysis, By Product (Kits & Reagents and Services), By Application(Cancer, CVD, Infectious Diseases), By Workflow(Isolation Methods, Downstream Analysis), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2851 | Region: Global | Published Date: April, 2024
Pages: 221 | Tables: 87 | Figures: 76

Exosome Research Products Market News

  • In July 2022, Cells for Cells, a clinical-stage biotech pioneering allogeneic stem cell and stem-cell-derived therapeutics for high-effect continual sicknesses, introduced a 6-month follow-up of the groundbreaking medical statistics from the first-ever patient dosed with an exosome-produced remedy for osteoarthritis.
  • In April 2022, Global Stem Cells Group (GSCG) announced the release of its new product with new lyophilized exosome era. Global Stem Cells Group's new product line includes modern anti-getting older products which could regenerate cells and tissues in the frame.
  • In November 2021, Lonza, a global production accomplice to the pharma, biotech, and nutrients industries, introduced the purchase of an exosome manufacturing facility in Lexington, Massachusetts (US) from Codiak BioSciences, a clinical-stage biopharmaceutical organization pioneering the development of exosome-based totally therapeutics.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Exosome Research Products Market size was valued at USD 250.8 Million in 2022 and is poised to grow from USD 325.79 Million in 2023 to USD 2641.25 Million by 2031, growing at a CAGR of 29.9% in the forecast period (2024-2031).

exosome research products market is highly competitive and consists of a number of major players. Key players are focusing on stretegic partnership to improve their product offerings. In October 2022, FUJIFILM Diosynth Biotechnologies strategically partnered with RoosterBio to develop GMP-compliant exosome and cell therapies.Top Player’s Company Profiles 'Thermo Fisher Scientific Inc.', 'QIAGEN N.V.', 'NanoSomiX Inc.', 'System Biosciences LLC', 'Malvern Instruments Ltd.', 'Bio-Techne Corporation', 'Norgen Biotek Corp.', 'Lonza Group Ltd.', 'HansaBioMed Life Sciences Ltd.', 'AMS Biotechnology (Europe) Ltd.', 'Hitachi Chemical Co. Ltd.', 'Evomic Science LLC', 'Codiak Biosciences Inc.', 'Exosome Diagnostics Inc.', 'Aethlon Medical Inc.', 'Evox Therapeutics Ltd.', 'Jazz Pharmaceuticals plc', 'ReNeuron Group plc', 'Capricor Therapeutics Inc.', 'Stem Cells Inc.'

The increasing reputation of the significance of exosomes in intercellular verbal exchange, biomarker discovery, and disease pathogenesis is using research hobby in exosome-related merchandise. Researchers are exploring exosomes' ability packages in diagnostics, therapeutics, and drug shipping, fueling call for exosome research merchandise.

One key marketplace trend within the exosome research products market is the growing adoption of advanced isolation and analysis technologies. Researchers are in search of progressive strategies and tools for setting apart exosomes from complicated biological samples, together with blood, urine, and tissue fluids, with high purity and yield. Additionally, there's a developing call for integrated structures that enable comprehensive characterization and useful analysis of exosomes, including their shipment molecules, surface markers, and biological sports.

North America dominated the market as increasing R&D investments are expected to drive the market growth. Large players such as Hologic Inc., Luminex Corporation and Thermo Fisher Scientific have a strong presence in the North American region. North America plays an important role in the growth of the exosome research products market. With a network of leading research institutes, biotech companies, and funds actively involved in exosome research in North America, particularly in the United States, the region benefits from an internal ecosystem is a strong supporter of scientific innovation, technological development and commercialization efforts in the field of exosome biology. North America is expected to be dominated by major market players having a large consumer market with high GDP. It is expected that the U.S. will grow due to increasing technological advances in exosome sensing materials.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Exosomes Market
Buy Now GET FREE SAMPLE
Biopharmaceuticals Excipients Market
Buy Now GET FREE SAMPLE
Nutraceutical Excipient Market
Buy Now GET FREE SAMPLE
Biotech Ingredients Market
Buy Now GET FREE SAMPLE
Targeted Liposomes Drug Delivery Market
Buy Now GET FREE SAMPLE
Pharmaceutical Excipients Market
Buy Now GET FREE SAMPLE
Gelatin Substitutes Market
Buy Now GET FREE SAMPLE
Enteric Softgel Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Exosome Research Products Market

Report ID: SQMIG35A2851

$5,300
BUY NOW GET FREE SAMPLE